Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01685996 · ClinicalTrials.gov registry record · Phase 1

Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation

A Phase 1 study, sponsored by Johns Hopkins University.

Completed
Registry status
Phase 1
Development phase
74
Enrollment target

NCT01685996: Completed Phase 1 study, sponsored by Johns Hopkins University.

NCT01685996 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 74 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (23% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01685996, a Phase 1 study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
Phase 1
Development phase
74 participants
Enrollment target

Study Summary

Randomized trial to evaluate whether zonisamide can enhance varenicline-induced smoking cessation.

Primary Outcome

Biochemically-verified continuous smoking abstinence during weeks 7-10 of the study.

Interventions

  • DRUG placebo
  • DRUG zonisamide

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2012-09
Est. Completion 2014-05
Phase Phase 1
Johns Hopkins University

1,448 total trials

What the finished NCT01685996 record still lists

NCT01685996 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (23% higher).

The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.

NCT01685996 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01685996 about?

NCT01685996 is a clinical study titled "Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation". Randomized trial to evaluate whether zonisamide can enhance varenicline-induced smoking cessation.

What is the current status of trial NCT01685996?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 74 participants. The study started on 2012-09. Estimated completion is 2014-05.

What interventions are being tested in trial NCT01685996?

The interventions under investigation include: placebo (DRUG), zonisamide (DRUG).

Who is sponsoring clinical trial NCT01685996?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01685996's enrollment target sits among peer trials

74 725th of 2000 higher than 1,269 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03422731 · 74 participants · Early Phase 1

    Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

  • NCT03804853 · 74 participants · NA

    Rehabilitation Following Reverse Total Shoulder Arthroplasty

  • NCT04065776 · 74 participants · NA

    Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

  • NCT04771156 · 74 participants · Phase 4

    Ketorolac in Palatoplasty

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01685996, the US trial registry maintained by the National Library of Medicine. NCT01685996 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.